Effective immediately and with full implementation by January 2028, Optum Rx will align payment models more closely to the costs pharmacies may face due to manufacturer pricing actions.
Optum Rx's new cost-based program uses an internal algorithm that leverages multiple available industry data sources, such as NADAC and PAC, to inform reimbursement. Optum Rx is implementing a new ...
Optum Rx announced Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs. The pharmacy benefit management arm of UnitedHealth Group said it will work with ...
UnitedHealth Group (NYSE:UNH) announced Wednesday its pharmacy benefit manager, Optum Rx, would eliminate up to 25% of reauthorizations, easing patients’ access to multiple medications when ...
Optum Rx is moving to eliminate prior authorizations on dozens of drugs, the UnitedHealth-owned pharmacy benefit manager said Wednesday, paring back a key pain point for physicians and patients ...
Optum Rx has eliminated reauthorization for almost 70 drugs for chronic diseases, about 10% of its overall pharmacy prior authorizations. Optum Rx is eliminating reauthorization on almost 70 drugs for ...
More than 3,000 payer groups covering more than 62 million lives use Optum’s services. Additional evaluation information is here. The 37 health systems Optum recommends for cancer care in 2025: ...
Advertisement Article continues below this ad But one week after votes were tallied, their employer — Optum, a UnitedHealth Group subsidiary and the company that has owned Crystal Run since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results